| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.08 |